Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,928 | 25,146 | 25,933 | 25,408 | 25,818 |
| Receivables | 362 | 242 | 175 | 1,205 | 1,119 |
| TOTAL | $25,381 | $25,501 | $26,272 | $26,855 | $27,067 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 20 | 23 | 138 | 146 | 156 |
| TOTAL | $20 | $23 | $138 | $146 | $156 |
| Total Assets | $25,401 | $25,524 | $26,410 | $27,001 | $27,223 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 376 | 440 | 401 | 345 | 290 |
| TOTAL | $388 | $452 | $413 | $359 | $307 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 111 | 100 | 119 | 111 | 99 |
| TOTAL | $111 | $100 | $119 | $111 | $99 |
| Total Liabilities | $499 | $552 | $532 | $469 | $406 |
| Shareholders' Equity | |||||
| Common Shares | 21,270 | 21,103 | 21,622 | 22,090 | 22,140 |
| Retained earnings | 3,095 | 3,336 | 3,711 | 3,889 | 4,126 |
| Other shareholders' equity | 8 | 8 | 8 | 9 | 8 |
| TOTAL | $24,902 | $24,972 | $25,878 | $26,532 | $26,817 |
| Total Liabilities And Equity | $25,401 | $25,524 | $26,410 | $27,001 | $27,223 |